Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells

Immunology - Tập 123 Số 3 - Trang 447-455 - 2008
David Askew1, Clifford V. Harding2
1Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106 USA
2Department of Pathology, Case Western Reserve University, Cleveland, OH, USA

Tóm tắt

Summary

To examine heterogeneity in dendritic cell (DC) antigen presentation function, murine splenic DCs were separated into CD4+ and CD8+ populations and assessed for the ability to process and present particulate antigen to CD4+ and CD8+ T cells. CD4+ and CD8+ DCs both processed exogenous particulate antigen, but CD8+ DCs were much more efficient than CD4+ DCs for both major histocompatibility complex (MHC) class II antigen presentation and MHC class I cross‐presentation. While antigen processing efficiency contributed to the superior antigen presentation function of CD8+ DCs, our studies also revealed an important contribution of CD24. CD8+ DCs were also more efficient than CD4+ DCs in inducing naïve T cells to acquire certain effector T‐cell functions, for example generation of cytotoxic CD8+ T cells and interferon (IFN)‐γ‐producing CD4+ T cells. In summary, CD8+ DCs are particularly potent antigen‐presenting cells that express critical costimulators and efficiently process exogenous antigen for presentation by both MHC class I and II molecules.

Từ khóa


Tài liệu tham khảo

10.1084/jem.172.5.1459

10.1084/jem.178.2.509

10.1084/jem.171.1.159

10.1084/jem.182.2.389

10.1084/jem.188.2.373

10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3

10.1097/00007890-200201151-00005

10.1084/jem.190.2.229

10.4049/jimmunol.166.12.7042

10.1136/bjo.83.5.598

10.4049/jimmunol.164.3.1346

Vremec D, 1997, Dendritic cell subtypes in mouse lymphoid organs. cross‐correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes, J Immunol, 159, 565, 10.4049/jimmunol.159.2.565

10.4049/jimmunol.165.12.6762

10.4049/jimmunol.164.6.2978

10.1038/nri746

10.1084/jem.194.8.1171

10.1084/jem.183.1.237

10.4049/jimmunol.170.5.2323

10.4049/jimmunol.172.2.1009

10.1182/blood.V100.2.383

10.1002/1521-4141(200203)32:3<686::AID-IMMU686>3.0.CO;2-I

10.1189/jlb.69.6.951

10.1084/jem.192.12.1685

10.4049/jimmunol.166.9.5327

10.1084/jem.20020161

10.1182/blood.V96.9.3029

10.1002/jlb.66.2.242

10.1084/jem.189.3.587

10.4049/jimmunol.167.8.4345

10.1006/smim.2001.0323

10.1073/pnas.96.3.1036

10.4049/jimmunol.166.9.5448

10.1038/361359a0

10.4049/jimmunol.147.9.2860

10.1016/0022-1759(91)90325-A

Pulendran B, 1997, Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand‐treated mice, J Immunol, 159, 2222, 10.4049/jimmunol.159.5.2222

10.1084/jem.176.1.47

10.1182/blood.V98.13.3520

10.1016/S0198-8859(02)00748-6

10.1182/blood.V99.3.999

10.1182/blood.V100.5.1734.h81702001734_1734_1741

10.4049/jimmunol.172.2.1018

10.1146/annurev.immunol.20.091101.091806

10.1038/nri727

10.1186/gb-2005-6-6-223

10.1084/jem.175.2.437

10.1084/jem.187.7.1151

10.1084/jem.185.2.251

10.1016/j.imlet.2004.05.009

10.1073/pnas.0601956103

10.1084/jem.20020295